Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade

Inducing immunogenic tumor cell death to stimulate the response to immune checkpoint blockade has not yet been effectively translated into clinical practice. We recently discovered that stressed/injured but still viable tumor cells are critical for T-cell priming and substantially improve responses...

Full description

Bibliographic Details
Main Authors: Sriram, Ganapathy, Emmons, Tiffany R, Milling, Lauren E, Irvine, Darrell J, Yaffe, Michael B
Other Authors: Massachusetts Institute of Technology. Department of Biology
Format: Article
Language:English
Published: Informa UK Limited 2023
Online Access:https://hdl.handle.net/1721.1/147026
_version_ 1826204757207810048
author Sriram, Ganapathy
Emmons, Tiffany R
Milling, Lauren E
Irvine, Darrell J
Yaffe, Michael B
author2 Massachusetts Institute of Technology. Department of Biology
author_facet Massachusetts Institute of Technology. Department of Biology
Sriram, Ganapathy
Emmons, Tiffany R
Milling, Lauren E
Irvine, Darrell J
Yaffe, Michael B
author_sort Sriram, Ganapathy
collection MIT
description Inducing immunogenic tumor cell death to stimulate the response to immune checkpoint blockade has not yet been effectively translated into clinical practice. We recently discovered that stressed/injured but still viable tumor cells are critical for T-cell priming and substantially improve responses to systemic anti-PD1/CTLA4. Therapeutic tumor cell injury, rather than complete killing, in the tumor microenvironment may enhance efficacy of immunotherapy in various cancers.
first_indexed 2024-09-23T13:00:36Z
format Article
id mit-1721.1/147026
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T13:00:36Z
publishDate 2023
publisher Informa UK Limited
record_format dspace
spelling mit-1721.1/1470262023-01-10T03:23:55Z Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade Sriram, Ganapathy Emmons, Tiffany R Milling, Lauren E Irvine, Darrell J Yaffe, Michael B Massachusetts Institute of Technology. Department of Biology Inducing immunogenic tumor cell death to stimulate the response to immune checkpoint blockade has not yet been effectively translated into clinical practice. We recently discovered that stressed/injured but still viable tumor cells are critical for T-cell priming and substantially improve responses to systemic anti-PD1/CTLA4. Therapeutic tumor cell injury, rather than complete killing, in the tumor microenvironment may enhance efficacy of immunotherapy in various cancers. 2023-01-09T18:45:45Z 2023-01-09T18:45:45Z 2022 2023-01-09T18:32:52Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/147026 Sriram, Ganapathy, Emmons, Tiffany R, Milling, Lauren E, Irvine, Darrell J and Yaffe, Michael B. 2022. "Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade." Molecular & Cellular Oncology, 9 (1). en 10.1080/23723556.2022.2039038 Molecular & Cellular Oncology Creative Commons Attribution 4.0 International license https://creativecommons.org/licenses/by/4.0/ application/pdf Informa UK Limited Taylor & Francis
spellingShingle Sriram, Ganapathy
Emmons, Tiffany R
Milling, Lauren E
Irvine, Darrell J
Yaffe, Michael B
Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade
title Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade
title_full Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade
title_fullStr Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade
title_full_unstemmed Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade
title_short Immunogenic cell stress and injury versus immunogenic cell death: implications for improving cancer treatment with immune checkpoint blockade
title_sort immunogenic cell stress and injury versus immunogenic cell death implications for improving cancer treatment with immune checkpoint blockade
url https://hdl.handle.net/1721.1/147026
work_keys_str_mv AT sriramganapathy immunogeniccellstressandinjuryversusimmunogeniccelldeathimplicationsforimprovingcancertreatmentwithimmunecheckpointblockade
AT emmonstiffanyr immunogeniccellstressandinjuryversusimmunogeniccelldeathimplicationsforimprovingcancertreatmentwithimmunecheckpointblockade
AT millinglaurene immunogeniccellstressandinjuryversusimmunogeniccelldeathimplicationsforimprovingcancertreatmentwithimmunecheckpointblockade
AT irvinedarrellj immunogeniccellstressandinjuryversusimmunogeniccelldeathimplicationsforimprovingcancertreatmentwithimmunecheckpointblockade
AT yaffemichaelb immunogeniccellstressandinjuryversusimmunogeniccelldeathimplicationsforimprovingcancertreatmentwithimmunecheckpointblockade